Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 19;12(1):ofae741.
doi: 10.1093/ofid/ofae741. eCollection 2025 Jan.

Osteomyelitis and Septic Arthritis in the Darwin Prospective Melioidosis Study

Affiliations

Osteomyelitis and Septic Arthritis in the Darwin Prospective Melioidosis Study

Stuart Campbell et al. Open Forum Infect Dis. .

Abstract

Background: Melioidosis is a multisystem infectious disease caused by the environmental bacterium Burkholderia pseudomallei. Osteomyelitis (OM) and septic arthritis (SA) are uncommon primary presentations for melioidosis but important secondary foci, often requiring prolonged therapy and multiple surgeries. We characterized the epidemiology, presentation, treatment, and outcomes of patients from 24 years of the Darwin Prospective Melioidosis Study (DPMS).

Methods: DPMS patients from October 1, 1999, until September 30, 2023, were included if they had a primary or secondary diagnosis of OM or SA. Epidemiological, risk factor, clinical, and outcome data were retrieved from the DPMS database. Antibiotic and surgical data were collated from patient records.

Results: From 1129 consecutive patients with culture-confirmed melioidosis, 122 (10.8%) had OM and/or SA, with 115 evaluable. Ninety-four of 1129 (8.3%) had OM, and 62/1129 (5.5%) had SA, with 41/115 (35.7%) of these having both OM and SA. Many combined infections involved contiguous bone and joints or soft tissue. Fifty-nine (51.3%) were male, and only 4.3% were ≤16 years old. Diabetes mellitus was present in 69.6%, and only 12.2% had no identifiable clinical risk factor. There were 8 deaths (7.0%) and 20 (17.4%) recurrent infections. Seventy-one (61.7%) had operative management, with combined infection associated with more procedures and longer length of stay.

Conclusions: The current paradigm of care for osteoarticular melioidosis involves prolonged intravenous antibiotics in conjunction with timely and complete operative management, and in our setting where these are available, outcomes are good. In many melioidosis-endemic regions these resources are limited, and mortality remains high.

Keywords: Burkholderia pseudomallei; bone and joint infection; melioidosis; osteomyelitis; septic arthritis.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Diagram of the cumulative total foci of infection (both septic arthritis and osteomyelitis) for 115 patients with osteoarticular melioidosis in the Darwin Prospective Melioidosis Study (DPMS). aRepresents foci with significant differences between groups. bSeven patients had 2 involved joints, and 6 had 3 involved joints. cTwelve patients had 2 osteomyelitis foci, and 8 had 3 foci.
Figure 2.
Figure 2.
Kaplan-Meier failure curve comparing the proportion of patients with recurrent melioidosis over time since discharge from acute admission between conservative (nonoperative) or operative management strategies.

References

    1. Meumann EM, Limmathurotsakul D, Dunachie SJ, Wiersinga WJ, Currie BJ. Burkholderia pseudomallei and melioidosis. Nat Rev Microbiol 2024; 22:155–69. - PubMed
    1. Yee KC, Lee MK, Chua CT, Puthucheary SD. Melioidosis, the great mimicker: a report of 10 cases from Malaysia. J Trop Med Hyg 1988; 91:249–54. - PubMed
    1. Currie BJ, Mayo M, Ward LM, et al. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. Lancet Infect Dis 2021; 21:1737–46. - PubMed
    1. Dadwal P, Bonner B, Fraser D, et al. Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes. PLoS Negl Trop Dis 2024; 18:e0012317. - PMC - PubMed
    1. Shetty RP, Mathew M, Smith J, Morse LP, Mehta JA, Currie BJ. Management of melioidosis osteomyelitis and septic arthritis. Bone Joint J 2015; 97-B:277–82. - PubMed